Latest Episodes
14
Exploring the Value Add of In-Study Interviews as a critical COA Endpoint
In this episode of TransPerfect LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences sits down with Tom Willgoss, Patient-Centered Outcomes Research...
13
Breaking the Hype Cycle: An Objective Look at Remote Research Strategies in DCTs
In the first part of TransPerfect's latest LifeSci Talks episode, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, with guest Dr. Michelle Longmire,...
12
Exploring the Intersection of Clinical Practice and Entrepreneurship: Technological Innovation in Clinical Research
In this episode of TransPerfect LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, sits down with Dr Michelle Longmire, CEO of...
10
PRO Scheduling Considerations: Assessing Patient & Caregiver Burden in Clinical Trials
In this episode of TransPerfect LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences sits down with Andrew Lloyd, Director at Acaster-Lloyd...
9
Licensing Considerations and eCOA Vendor Collaborations
In this episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, sits down with Stacey Higgins, Associate Director, COA &...
9
Decoding Decentralized Trials: Navigating Novel Decentralized Research Challenges and Complexity with Craig Lipset
DCTs have picked up significantly in previous years, catalyzed by the pandemic and a move to remote research. With this move comes a host...